Patent US3278817A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4399227A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for determination of glycosylated hemoglobin and reagent therefor

Assignee: PANCHEM GESELLSCHAFT fur CHEMISCHE PRODUKTE MBH A CORP OF GERMANY
•
Filing: 1982-02-19
•
Granted: 1983-08-16
•
Expires: 2002-02-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An improved process for determining glycosylated hemoglobin wherein the contribution of unstable glucose-aldimine-hemoglobin compounds to the HbA 1 value is substantially eliminated by reacting the hemolysate with a primary amine and a hydrazine compound and thereafter subjecting the hemolysate to chromatography. The process enables reliable evaluation of the HbA 1 value as a long-term parameter in diabetic metabolism control.

Inventors

  • 👤 Cornelia Niederau
  • 👤 Hans Reinauer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 16:39
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/72; G01N33/721; G01N33/723; Y; Y10; Y10T; Y10T436/00; Y10T436/25; Y10T436/25125

Claims Analysis

Total Claims: 29
Claim 1
Independent Claim 66 words
In a process for the determination of the glycosylated hemoglobin content of a blood sample comprising the hemolysis of erythrocytes, the chromatographic separation of hemoglobin fractions and their colorimetric measurement, the improvement wherein the contribution of unstable glucose-aldimine-hemoglobin compounds to the HbA 1 value is substantially eliminated by reacting the hemolysate with a primary amine and a hydrazine compound and thereafter subjecting the hemolysate to chromatography.
Claim 2
Dependent Claim 66 words
In a process for the determination of the glycosylated hemoglobin content of a blood sample comprising the hemolysis of erythrocytes, the chromatographic separation of hemoglobin fractions and their colorimetric measurement, the improvement wherein the contribution of unstable glucose-aldimine-hemoglobin compounds to the HbA 1 value is substantially eliminated by reacting the hemolysate with a primary amine and a hydrazine compound and thereafter subjecting the hemolysate to chromatography.
Claim 3
Dependent Claim 24 words
A process according to claim 1, wherein the hemolysis and the reaction with a primary amine and a hydrazine compound are carried out simultaneously.
Claim 4
Dependent Claim 24 words
A process according to claim 1, or 2, wherein the primary amine comprises hydroxylamine, an alkylamine, a hydroxyalkylamine, an amino acid, aniline or pyridoxamine.
Claim 5
Dependent Claim 12 words
A process according to claim 3 wherein the primary amine comprises hydroxylamine.
Claim 6
Dependent Claim 13 words
A process according to claim 3 wherein the primary amine comprises an alkylamine.
Claim 7
Dependent Claim 14 words
A process according to claim 5 wherein the primary amine comprises ethylamine or propylamine.
Claim 8
Dependent Claim 13 words
A process according to claim 3 wherein the primary amine comprises a hydroxyalkylamine.
Claim 9
Dependent Claim 12 words
A process according to claim 7 wherein the primary amine comprises ethanolamine.
Claim 10
Dependent Claim 14 words
A process according to claim 3 wherein the primary amine comprises an amino acid.
Claim 11
Dependent Claim 12 words
A process according to claim 9 wherein the primary amine comprises lysine.
Claim 12
Dependent Claim 12 words
A process according to claim 9 wherein the primary amine comprises valine.
Claim 13
Dependent Claim 17 words
A process according to claim 9 wherein the primary amine comprises a mixture of lysine and valine.
Claim 14
Dependent Claim 17 words
A process according to claim 1 or 2 wherein the hydrazine compound comprises hydrazine, phenylhydrazine or semicarbazide.
Claim 15
Dependent Claim 12 words
A process according to claim 13 wherein the hydrazine compound comprises hydrazine.
Claim 16
Dependent Claim 12 words
A process according to claim 13 wherein the hydrazine compound comprises phenylhydrazide.
Claim 17
Dependent Claim 12 words
A process according to claim 13 wherein the hydrazine compound comprises semicarbazide.
Claim 18
Dependent Claim 15 words
A process according to claim 3 wherein the hydrazine compound comprises hydrazine, phenylhydrazine or semicarbazide.
Claim 19
Dependent Claim 15 words
A process according to claim 9 wherein the hydrazine compound comprises hydrazine, phenylhydrazine or semicarbazide.
Claim 20
Dependent Claim 15 words
A process according to claim 10 wherein the hydrazine compound comprises hydrazine, phenylhydrazine or semicarbazide.
Claim 21
Dependent Claim 15 words
A process according to claim 11 wherein the hydrazine compound comprises hydrazine, phenylhydrazine or semicarbazide.
Claim 22
Dependent Claim 15 words
A process according to claim 12 wherein the hydrazine compound comprises hydrazine, phenylhydrazine or semicarbazide.
Claim 23
Dependent Claim 72 words
In a process for the determination of the glycosylated hemoglobin content of a blood sample comprising the hemolysis of erythrocytes, the chromatographic separation of hemoglobin fractions and their colorimetric measurement, the improvement wherein the contribution of unstable glucose-aldimine-hemoglobin compounds to the HbA 1 value is substantially eliminated by reacting the hemolysate with hydroxylamine, an alkylamine, a hydroxyalkylamine or an amino acid and a hydrazine compound and thereafter subjecting the hemolysate to chromatography.
Claim 24
Dependent Claim 72 words
In a process for the determination of the glycosylated hemoglobin content of a blood sample comprising the hemolysis of erythrocytes, the chromatographic separation of hemoglobin fractions and their colorimetric measurement, the improvement wherein the contribution of unstable glucose-aldimine-hemoglobin compounds to the HbA 1 value is substantially eliminated by reacting the hemolysate with hydroxylamine, an alkylamine, a hydroxyalkylamine or an amino acid and a hydrazine compound and thereafter subjecting the hemolysate to chromatography.
Claim 25
Dependent Claim 12 words
A process according to claim 22 wherein the hydrazine compound is hydrazine.
Claim 26
Dependent Claim 12 words
A process according to claim 22 wherein the hydrazine compound is phenylhydrazine.
Claim 27
Dependent Claim 12 words
A process according to claim 22 wherein the hydrazine compound is semicarbazide.
Claim 28
Dependent Claim 49 words
A reagent for use in the process according to claim 2, said reagent comprising lysine, valine, semicarbazide and digitonin in amounts effective to substantially eliminate the contribution of unstable glucose-aldimine-hemoglobin compounds to the HbA 1 value, together with sufficient phosphate buffer to establish a pH value of approximately 6.6.
Claim 29
Dependent Claim 36 words
A reagent according to claim 22, said reagent containing 20 mM lysine, 20 mM valine, 200 mM semicarbazide hydrochloride, 50 mM sodium phosphate buffer (for pH 6.6) and 0.813 mM digitonin per liter of aqueous solution.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-08-15 1987-02-14 1987-08-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-08-15 1991-02-14 1991-08-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-08-15 1995-02-14 1995-08-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag